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*3303 and DRB1*1301 were the predominant subtypes
f HLA-A*33 and DRB1*13 alleles in Iranian HBV infected
atients.
oi:10.1016/j.ijid.2010.02.1984
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epatitis A epidemiology in a Brazilian ﬁre department
. Borghi1,∗, R.P. Igreja2, M.D. Canetti 1, R.C.
asconcellos1, C.L. Vitral 3, D.R.L. Santos3
Fire Department, Rio de Janeiro, Brazil
Universidade Federal do Rio de Janeiro, Rio de Janeiro,
razil
Instituto Oswaldo Cruz, Rio de Janeiro, Brazil
Background: In developing countries, the ﬁrst contact
ith hepatitis A virus (HAV) occurs early in life. In recent
ears, the improvement on sanitation conditions in some
eveloping areas resulted in an increase of proportion of the
opulation that reaches adulthood without acquired immu-
ity. In Brazil, although hepatitis A is considered an endemic
isease, data published in recent investigations carried out
n the State of Rio de Janeiro revealed a shift in the hepati-
is A epidemiological pattern. Consequently studies must be
onducted to deﬁne the seroprevalence of anti-HAV antibod-
es in different populations and a programme to vaccinate
on immune people must be created.
Methods: To ﬁnd out the seroprevalence of anti-HAV
ntibodies in a population professionally exposed to water
ontact (ﬂooding, sea and fresh water) living in Rio de
aneiro, Brazil. A secondary objective was to evaluate the
ost-beneﬁt of performing serological screening prior to
accination. Participants were military ﬁreman from the
tate of Rio de Janeiro, that ﬁlled in a socioeconomic
uestionnaire. Blood specimens were obtained for anti-HAV
erological test (ELISA). The results were analyzed using t-
tudent test and 2 test, as well as a logistic regression.
Results: Nine hundred and thirty one participants were
nrolled in the study. The median age of the population was
8 years and the overall seroprevalence of anti-HAV was
8.5%. The distribution of positive tests according to age
roups were 47,8% in 20—25 years, 53,4%% in 26—30 years,
9,4% in 31—35 years, 87,2% in 36—40 years, 88,6% in 41—45
ears and 91% in > 46 years.
Conclusion: Military ﬁreman from Rio de Janeiro have a
igh level of immunity against HAV. The results of cost bene-
t showed that the population which has a prevalence of up
o 27%, should be vaccinated without serological screening.
s the lower prevalence of this group was 47.8%, everyone
hould undertake serology before being vaccinated.
oi:10.1016/j.ijid.2010.02.1985
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ssociation of exon 9 but not intron 8 VDR polymorphisms
ith occult HBV infection in southeastern Iranian patients
. Hassanshahiraviz
Faculty of medicine, rafsanjan, kerman, Iran (Islamic
epublic of)
Background: Occult hepatitis B infection (OBI) is charac-
erized as a form of hepatitis in which despite of absence of
etectable hepatitis B surface antigen (HBsAg), HBV-DNA is
resent in patient’s peripheral blood. Investigators believe
hat divergent genetics and immunological parameters are
arying in resistant individuals from patients. Vitamin D3 and
t’s known receptor seem to be involved in anti-viral immune
esponses. Therefore, because OBI is a form of viral infec-
ion, the aim of this study was to investigate the association
etween polymorphisms in intron 8 and exon 9 of vitamin D
eceptor (VDR) with OBI.
Methods: In this experimental study, the plasma sam-
les of 3700 blood donors were collected and tested for
BsAg and anti-HBs using ELISA. The HBsAg-/anti-Hepatitis
core+(anti-HBc) samples were selected and screened for
BV-DNA using PCR. HBV-DNA positive samples assigned as
BI cases and PCR-RFLP was performed to examine the poly-
orphisms in intron 8 and exon 9 of VDR.
Results: Results of the current study demonstrated that
52 (9.5%) of 3700 blood samples were HBsAg−/anti-HBc+.
BV-DNA was detected in 57/352 (16.1%) of HBsAg-/anti-
Bc+ samples. Our results showed signiﬁcant difference in
/T allele of exon 9 of VDR but any differences were also
bserved in the other examined alleles.
Conclusion: The polymorphisms in T/T allele of exon 9 of
DR is possibly associated with OBI thus it can be concluded
hat VDR and its functional polymorphisms can probably
ave a relation with sensitivity and resistance of immune
ystem to HBV in OBI patients.
oi:10.1016/j.ijid.2010.02.1986
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L-12 +1188 and IFN-g +874 polymorphisms is not asso-
iated with these cytokines serum level in occult HBV
nfected patients
. Abousaidi
Faculty of medicine, rafsanjan, kerman, Iran, (Islamic
epublic of)
Background: Occult hepatitis B infection (OBI) is identi-
ed as a form of hepatitis in which despite of absence of
etectable HBsAg, HBV-DNA is observed in peripheral blood
f patients. The main aim of this study was to investigate
he association between polymorphisms in +874 of IFN-g and
1188 of IL-12 with their serum level in patients suffering
rom OBI.
Methods: In this experimental study, plasma samples of
700 blood donors were tested for HBsAg and anti-HBc by
LISA. The HBsAg-/anti-HBc+ samples were selected and
creened for HBV-DNA by PCR. HBV-DNA positive samples
ssigned as OBI cases and ARMS-PCR techniques was per-
ormed to examine the polymorphisms in IL-12 and IFN-g.
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The serum level of IL-12 and IFN-g was also detected by
ELISA.
Results: Results of this study demonstrated that, 352
(9.5%) out of 3700 blood samples were HBsAg-/anti-HBc+
and HBV-DNA was detected in 57/352 (16.1%) of HBsAg-
/anti-HBc+ samples. Our results showed that groups showed
signiﬁcant difference in CC allele of +1188 region of IL-
12 and no difference was observed in the other evaluated
genes. Our results also showed that the alleles of +1188
region of IL-12 and alleles of +874 of IFN-g were also not
associated with serum level of cytokines.
Conclusion: According to the results of this study it may
be concluded that the polymorphisms in +1188 region of IL-
12 and +874 region of IFN-g would not affect the expression
of both cytokines at serum level in OBI patients.
doi:10.1016/j.ijid.2010.02.1987
53.006
Occult hepatitis B virus infection in ART-naive HIV-
infected Indian patients
S. Singh
All India Institute of Medical Sciences, New Delhi, India
Background: Hepatitis viruses are frequently found as a
co-infection with HIV due to shared routes of transmission.
Globally the most common method of diagnosis is serology,
which can only detect active HBV infection while the occult
HBV infection may be missed. We estimated the burden of
HBV infection in patients who were tested positive for HIV
at a tertiary care centre in north India. We also attempted
to determine the prevalence and clinical characteristics of
occult HBV among these treatment-naïve patients and com-
pare their demographics features with other HIV patients.
Methods: During a period of 6 years between January
2002 to December 2007 837 HIV positive patients were
tested for serological markers of HBV (HBsAg) and HCV IgM
in our laboratory. For comparison 428 apparently healthy,
HIV-negative organ donors were also included in the study.
Data on demographics, sexual behaviour, medical history,
laboratory tests viz., serum ALT and CD4 count of these
patients were recorded. A sub-group of 53 HBsAg negative
samples from HIV positive patients were randomly selected
and assessed for anti-HBs, anti-HBc total (IgG+IgM) and HBV-
DNA using a highly sensitive qualitative PCR and analysed
retrospectively.
Results: Overall, 7.3% of HIV positive patients showed
presence of HBsAg as compared to 1.4% in the HIV negative
control group. The prevalence was higher (8.55%) in males
than females (3.39%). Overall occult HBV with detectable
HBV-DNA was found in 37.5% patients; being 45.5% in anti-
HBs positive patients and 30.7% in patients positive for anti-
HBc antibodies alone.
Conclusion: High prevalence of HIV-HBV co-infection was
found in our patients. The most reliable method to diagnose
occult HBV co-infection in HIV seropositive patients is the
detection of HBV DNA.
doi:10.1016/j.ijid.2010.02.1988
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reatment of chronic hepatitis C: The efﬁcacy and pre-
ictors of response to therapy
. Bozic
Institute for Infectious and Tropic Diseases, Belgrade, SER-
IA, Serbia
Background: The current standard for therapy of chronic
epatitis C (CHC) is combination of pegylated interferon
lpha (PEG IFN-&2a or PEG IFN-&2b) and ribavirin (RBV). It
s universally accepted that achievement of Sustained Viro-
ogical Response (SVR) means successful treatment. Certain
actors are good predictors of treatment outcome and they
rovide optimal, individual therapeutic approach.
Objectives: Evaluation of efﬁcacy of CHC treatment and
redictors of treatment response.
Methods: 194 patients with CHC were treated with
ombination therapy (PEG IFN-&2a + RBV).Virological exam-
nations: anti-HCV antibodies (ELISA), serum HCV RNK levels
nd HCV genotypes (PCR technique). Liver biopsy specimens
ere staged in accordance with the Metavir score. Predic-
or with inﬂuence on treatment outcome were estimated by
ultivariable logistic regression analysis.
Results: There were more patients of male gender
59.3%), older then 40 years (58.2%), with high basal HCV-
NA level (> 800.000 IU/ml, 63%), with G1 HCV (67%) in
reated group of patients with CHC. Bridging ﬁbrosis and cir-
hosis (F3, F4) were found in 54 (27.8%) of patients. SVR was
chieved in 69.2%, relapse was found in 11.9% of patients.
9.8% of patients had no response on therapy. Predictors for
chievement of SVR were: non-1 HCV genotype p = 0.002,
R 5.9 95% CI (1.9—18.0), achievement of early virologi-
al response (EVR) p = 0.000, OR 0.92, 95% CI (2.73—35.97),
nd patients younger the 40 years p = 0.005, OR 3.66 95% CI
1.48-9.0). Predictors for failure of therapy for patients who
idn’t respond to treatment were: G1 HCV p = 0.005, OR 3.9,
5 CI (1.5—10.3), high basal viral load p = 0.013, OR 3.45,
5% CI (1.29—9.19) and interupted continuity of treatment
= 0.002, OR 4.49, 95% CI (1.72—11.76).
Conclusion: The current standard antiviral therapy was
fﬁcient in 127/194 (69.2%) of our patients. The most impor-
ant predictors for successful treatment (SVR) were: non-1
CV genotype, achievement of EVR for G1 HCV and patients
ge. Predictors for failure of treatment were: G1 HCV, high
asal viral load, older age (>40 years), presence of cirrhosis
nd discontinuity of treatment.
oi:10.1016/j.ijid.2010.02.1989
3.008
ccult hepatitis C virus infection among chronic liver dis-
ase patients in the United Arab Emirates
. Al-Moslih
University of Sharjah, P.O.Box 27272, Sharjah, United Arab
miratesBackground: Viral Hepatitis C (HCV) is one of the major
orld wide health problems. WHO estimates that about 3%
f the world’s population has been infected with HCV and
hat some 170 million are chronic carriers at risk of develop-
